Please login to the form below

Not currently logged in
Email:
Password:

Icon promotes Brendan Buckley to chief medical officer

In his new role he will serve as the CRO's lead medical expert

Icon Brendan BuckleyDublin-based clinical research organisation (CRO) Icon has promoted Professor Brendan Buckley to chief medical officer.

Prof Buckley joined the company as its 2011 acquisition of clinical trechnology firm Firecrest Clinical, which he co-founded and where he was senior vice president of medical affairs. 

In his new role, which will see him join the company's executive leadership team, he will serve as Icon's lead medical expert, representing the company's position on key scientific, ethical and medical governance matters.

He will also be tasked with providing guidance and oversight to company's medical and scientific groups.

Icon's CEO Ciaran Murray said: “Brendan's wealth of experience both as an advisor to European regulatory agencies and a physician with over 30 years of clinical trial experience, will help us advance our clients' products through their development pipelines and ensure Icon studies continue to be performed to the highest scientific and ethical standards.”

An endocrinologist with over 30 years' experience, Prof Buckley has been a board member of the Irish Medicines Board and of the European Medical Agency's (EMA) Scientific Advisory Group for Diabetes and Endocrinology since 2005.

Brendan is Clinical Professor of Medicine and Pharmacology at the School of Medicine, University College Cork (UCC), Ireland, and also chairs several independent Data and Safety Monitoring Boards for medium to large cardio-metabolic and rare disease clinical studies.

2nd July 2013

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics